APT Life Sciences

  • Bangalore, India
  • Healthcare, Life Sciences, hospitals

Improving the odds: the first-in-world whole-genome personalised medicine platform for cancer

Early Revenues

Startup Video



Team Summary

The Founding Team is highly qualified with experienced scientists (MD Anderson, NW Univ. Medical School) and engineering entrepreneurs (sold companies to WebEx and Google).


Product/Service Summary

APT’s genomic computational analysis platform, PeCaSo, powers its tumour-sample-to-physician report service solution for cancer patients through partnering hospitals in India. APT provides better personalised medicine choices to doctors by doing away with the limitations of the traditional approach of sequencing and mutation-based drug matching.

How are we different?

APT works with the patient's RNA instead of DNA. APT uses the whole genome and not just a tiny subset of genes that traditional gene-panel companies use. This leads to more treatment choices for the doctor.

Product/Service Descriptions